Bafoussam Regional Hospital
Bafoussam, Mifi, 00237, Cameroon
Location status: Recruiting
Location contact
Georges Enow Orock, MD
PRINCIPAL_INVESTIGATOR
Loïc Djommo, MSc
CONTACT
NCT Number: NCT06640075
Background - The burden of cervical cancer is unequally distributed globally, with over 90% of deaths occurring in low- and middle-income countries (LMICs), mainly due to insufficient uptake of preventive measures such as screening. In 2020, the World Health Organization launched a global initiative for the worldwide elimination of cervical cancer as a public health issue, setting a target of 70% of women screened with a high-performance test. In Cameroon, this target is far from being reached, and rural communities are disproportionately affected by low uptake of screening services. Recently, a new cervical cancer screening program has launched in the Bafoussam Regional Hospital, in the capital of the Mifi Health District, as part of a larger research project. To develop a context-specific strategy improving access to screening for women living in rural areas of the district, the active participation of community members for the co-development and implementation of local strategies for cervical cancer screening may be key to improving population screening coverage.
Objective - The aim of this study is to evaluate the use of community co-produced action (CCA) for the development and implementation of HPV-based cervical cancer screening strategies compared to a traditional hospital-based approach in rural areas of the Mifi Health District in Cameroon.
Methods - Using a cluster-randomized study design, participatory workshops with community members will be led in 7 rural health areas assigned to the intervention arm, with the aim of codeveloping local strategies for HPV-based cervical cancer screening adapted to the setting. The co-produced strategies may include raising awareness among eligible women (aged 30-49 years, or 25-49 years if HIV-positive), as well as facilitating access to screening tests, results and follow-up. Women living in one of the 7 health areas assigned to the control arm will be invited by community health workers to undergo screening at the Bafoussam Regional Hospital. In both study arms, screened women will be included in the GENOVA study, a cervical cancer screening trial offering free-of- charge HPV testing followed by triage by visual inspection or genotyping for HPV-positive women, and free treatment according to triage results. CCA will be evaluated by assessing its effectiveness for screening uptake. Screening coverage among eligible women will be estimated during one year after implementation of screening strategies in both study arms, based on population statistics provided by the Mifi health district for each health area.
Expected results - Developing context-sensitive solutions to cervical cancer screening through a community-based participatory approach in rural areas of the Mifi health district is expected to improve screening participation rate.
Interested in participating?
Request Info25 year–49 year
Female
Interventional
Not applicable
Bafoussam, Mifi, 00237, Cameroon
Location status: Recruiting
Georges Enow Orock, MD
PRINCIPAL_INVESTIGATOR
Loïc Djommo, MSc
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participatory workshops will be conducted with community members by a multidisciplinary team with the aim to co-develop a strategy for cervical cancer screening adapted to the local setting (including primary HPV screening, triage of HPV-positive patients and treatment of patients triaged positive). This intervention is referred to as 'community co-produced action'. Possible strategies co-developed may include collaboration with community health workers or local associations, awareness campaigns, development of health education materials, integration of primary HPV screening at local integrated health centers, organization of group transportation to the district screening center, etc.
Using purposive sampling methods, approximately 15 participants will be invited to take part in the workshops in each health area of the intervention, including approximately 3 health care providers, 3 community health workers or members of women's associations, 3 men and 6 eligible women for screening.
Recruitment of study participants will be coordinated centrally at district level (from the Bafoussam Regional Hospital) following procedures previously established in a cervical cancer screening program in the health district of Dschang. This standard procedure includes the training of 2 community health workers (CHW) by health area to raise awareness around cervical cancer. After an initial theoretical and practical training in cervical cancer prevention, CHWs recruit women by going door-to-door or through community meetings in their respective health areas. Through a system of nominal invitation vouchers distributed to eligible women, CHWs receive a financial incentive for each woman that shows up for cervical cancer screening. Twice a year, CHWs of all health areas are invited to a feedback session to discuss difficulties encountered on the field and propose solutions to face any identified challenges.
Time frame: HPV test within 12 months after implementation of the screening strategy at health-area level, and triage within 6 months of the HPV test if positive.
Complete screening (defined as an HPV test +/- triage for HPV-positive women) among the eligible population in both study arms.
Time frame: Within 12 months after implementation of the screening strategy at health-area level
Rate of primary screening (HPV test) among the eligible population in both study arms.
Time frame: Within 6 months after primary screening (HPV test)
Proportion of women with positive primary screening who proceed to completing triage and treatment (when needed) in both study arms
Time frame: From 11 to 15 months after primary screening
Proportion of HPV-positive women who attend the follow-up visit at 12 months after primary screening (HPV test) in both study arms
Time frame: At enrollment
Distribution of sociodemographic characteristics among screened women in both study arms
Contact information is provided by the study sponsor or research team.
Prof. Patrick Petignat
Other
Co-produced Community Action for Improved Access to Cervical Cancer Screening (Act4CC): a Mixed-methods Study in Rural Areas of the Mifi Health District
Acronym: Act4CC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07281599
Cervical Cancer (Early Detection), Cervical Cancer Cin Grade
New Haven, Connecticut, United States
View Trial DetailsNCT05092022
Cervical Cancer Screening, Female Urogenital Diseases
Reading, Pennsylvania, United States
View Trial DetailsNCT06800664
Cervical Cancer Screening, HIV
Cape Coast, Central Region, Ghana
View Trial DetailsNCT07538050
Cervical Cancer Screening
San Salvador, Oriente, El Salvador
View Trial Details